In a recent study (Lin et al., 2017a), we focused on the effects of rapamycin in presymptomatic mice carrying the human apolipoprotein ε4 (APOE4) allele, given that APOE4 is the most significant genetic risk factor for AD (Liu et al., 2013). The gene discussed is APOE; the disease is Alzheimer disease.